News

Industry News

View All » Industry News RSS Feed
FDA Announces Recall for Several Heart Medications Containing Valsartan

FDA Announces Recall for Several Heart Medications Containing Valsartan

The FDA has announced a voluntary recall of several drug products containing the active ingredient valsartan, which is used to treat high blood pressure and heart failure. This recall is due to an impurity, N-nitrosodimethylamine (NDMA), a probable human carcinogen (a substance that could cause cancer), which was found in the recalled products.

Read More »
FDA Approves First Drug Made from Active Ingredient from Marijuana for Severe Epilepsy

FDA Approves First Drug Made from Active Ingredient from Marijuana for Severe Epilepsy

The FDA has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome. This is the first FDA-approved drug that contains a purified drug substance derived from marijuana.

Read More »
Hospira Recalls Two Lots of Naloxone Hydrochloride

Hospira Recalls Two Lots of Naloxone Hydrochloride

Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of naloxone hydrochloride injection at the hospital/institution level due to the potential presence of embedded and loose particulate matter on the syringe plunger.

Read More »
FDA Approves Novel Preventive Treatment for Migraine

FDA Approves Novel Preventive Treatment for Migraine

The FDA has approved Aimovig (erenumab-aooe), a once-monthly, self-administered injection for the preventive treatment of migraine in adults. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that is involved in migraine attacks.

Read More »